2022
DOI: 10.1530/jme-22-0022
|View full text |Cite
|
Sign up to set email alerts
|

MCAD activation by empagliflozin promotes fatty acid oxidation and reduces lipid deposition in NASH

Abstract: Medium chain acyl-CoA dehydrogenase (MCAD) is one of the significant enzymes involved in β-oxidation of mitochondrial fatty acids. MCAD deficiency affects the β-oxidation of fatty acid and leads to lipid deposition in multiple organs, but little is known about its importance in nonalcoholic steatohepatitis (NASH). Empagliflozin is revealed to effectively improve NASH by increasing research, whereas the specific mechanism still has to explore. Human liver tissues of patients with or without NASH were obtained f… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 26 publications
0
1
0
Order By: Relevance
“…The previous study found that the MCAD levels in the liver were significantly reduced in NASH patients compared to patients without NASH. Moreover, upregulation of MCAD expression also reduced lipid deposition and improved NASH in vivo and in vitro ( 20 ). Therefore, based on the above results, it is concluded that hepatic fat accumulation in Wnt+ HFD-fed mice may be due to increased lipid synthesis and decreased oxidative catabolism caused by Wnt/β-catenin signaling activation.…”
Section: Discussionmentioning
confidence: 99%
“…The previous study found that the MCAD levels in the liver were significantly reduced in NASH patients compared to patients without NASH. Moreover, upregulation of MCAD expression also reduced lipid deposition and improved NASH in vivo and in vitro ( 20 ). Therefore, based on the above results, it is concluded that hepatic fat accumulation in Wnt+ HFD-fed mice may be due to increased lipid synthesis and decreased oxidative catabolism caused by Wnt/β-catenin signaling activation.…”
Section: Discussionmentioning
confidence: 99%
“…In the current study, we found that CPT1α was decreased in NAFLD mice and OA-induced cells, which was the same as in a previous study ( Pan et al, 2021 ). Moreover, Wang and colleagues indicates that the activation of the AMPK/Foxa2 pathway can upregulate the expression of medium-chain acyl-CoA dehydrogenase, thereby promoting fatty acid oxidation and reducing lipid accumulation in nonalcoholic steatohepatitis ( Wang et al, 2022 ). In our study, overexpression of Foxa2 reversed the upregulation of FAS and ACC and the downregulation of CPT1α in NAFLD mice and OA-stimulated HepG2 cells.…”
Section: Discussionmentioning
confidence: 99%